Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Johnson & Johnson Co DRC (JNJ)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
10,600.50 +19.50    +0.18%
05:59:00 - Closed. Currency in ARS ( Disclaimer )
  • Volume: 9,340
  • Bid/Ask: 10,545.00 / 10,610.00
  • Day's Range: 10,539.00 - 10,714.00
Type:  Equity
Market:  Argentina
ISIN:  ARDEUT110236 
Johnson & Johnson DRC 10,600.50 +19.50 +0.18%

JNJ Income Statement

 
Featured here, the Income Statement (earnings report) for Johnson & Johnson Co DRC, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Income Statement
Period Ending: 2023
01/01
2022
02/10
2022
03/07
2022
03/04
Total Revenue 23706 23791 24020 23426
Revenue 23706 23791 24020 23426
Other Revenue, Total - - - -
Cost of Revenue, Total 7729 7794 7902 7582
Gross Profit 15977 15997 16118 15844
Total Operating Expenses 17778 17193 17542 16683
Selling/General/Admin. Expenses, Total 6512 5802 5937 5639
Research & Development 3841 3597 3703 3462
Depreciation / Amortization -2028 685 644 669
Interest Expense (Income) - Net Operating - -51 -38 -10
Unusual Expense (Income) - - - -
Other Operating Expenses, Total 2205 -634 -606 -659
Operating Income 5624 6598 6478 6743
Interest Income (Expense), Net Non-Operating - - - -
Gain (Loss) on Sale of Assets - -200 -100 -250
Other, Net 1423 976 738 1131
Net Income Before Taxes 4201 5822 5840 5862
Provision for Income Taxes 681 1364 1026 713
Net Income After Taxes 3520 4458 4814 5149
Minority Interest - - - -
Equity In Affiliates - - - -
U.S GAAP Adjustment - - - -
Net Income Before Extraordinary Items 3520 4458 4814 5149
Total Extraordinary Items - - - -
Net Income 3520 4458 4814 5149
Total Adjustments to Net Income - - - -
Income Available to Common Excluding Extraordinary Items 3520 4458 4814 5149
Dilution Adjustment -4.63 -12.98 11.78 2.66
Diluted Net Income 3524.63 4470.98 4802.22 5146.34
Diluted Weighted Average Shares 2650.1 2661.3 2667.9 2666.5
Diluted EPS Excluding Extraordinary Items 1.32 1.68 1.8 1.93
DPS - Common Stock Primary Issue 1.13 1.13 1.13 1.06
Diluted Normalized EPS 1.49 1.6 1.58 1.62
* In Millions of (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

JNJ Comments

Write your thoughts about Johnson & Johnson Co DRC
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email